Cervical spondylotic myelopathy (CSM) refers to spinal cord compression from arthritis in the neck and is the leading cause of spinal cord dysfunction in older adults. CSM is a chronic, progressive ...
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares climbed 4.9% Tuesday following the commercial launch of ELEVIDYS gene therapy in Japan by Chugai Pharmaceutical Co., Ltd., after its reimbursement listing ...
Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with ...
Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.
CMTA invests $523,000 in four research projects focused on overcoming treatment delivery barriers in Charcot-Marie-Tooth disease. Getting treatments to the cells where they are needed has been a ...
Edgewise Therapeutics Inc. reports fourth-quarter results on Thursday, February 19, with investors weighing widening losses against the clinical-stage biotech’s progress toward what analysts call a ...
IAN Alpha Fund, the 2nd in the series of IAN Group’s VC funds, along with Speciale Invest, has co-led a ₹70 crore Series A ...
Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem – will seek to share a taste of those insights gleaned during that five-day press trip. It is hoped that some small part of ...
My twin sister spent years moving through consultations without a clear explanation for her symptoms. At one point, aged 31, ...
For many people, a voice is more than sound—it’s identity, independence, and connection. When illness, injury, or a congenital condition ...
Investing.com -- PTC Therapeutics (NASDAQ:PTCT) stock fell 4% in after-hours trading on Thursday after the company announced it had withdrawn its New Drug Application (NDA) resubmission for Translarna ...
Satellos Bioscience Inc. ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results